$SLS·4

Galena Biopharma, Inc. · Dec 22, 8:27 PM ET

Galena Biopharma, Inc. 4

4 · Galena Biopharma, Inc. · Filed Dec 22, 2015

Insider Transaction Report

Form 4
Period: 2015-12-18
Knapp Thomas J
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2015-12-18+225,000225,000 total
    Exercise: $1.50Exp: 2025-12-18Common Stock (225,000 underlying)
Footnotes (2)
  • [F1]Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.
  • [F2]The stock option will vest in 16 equal, quarterly installments over 4 years, beginning 3 months from the date of grant, so long as the Reporting Person remains in the company's continuous employ of the Issuer through the vesting period.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT